Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
In the TRIUMPH-1 Phase 3 trial, participants on the highest dose of retatrutide lost an average of 28.3% of their body weight at 80 weeks
These strategies collectively improve accuracy and reproducibility
References: [1] Aronne LJ, Sattar N, Horn DB, et al
Litigation history and pending exposure: any compounding facility with settled or pending patent, trademark, or false advertising litigation should be valued with a full disclosure-based analysis of the claimed damages, the settlement terms, and the injunctive relief exposure in any ongoing matter
US$ 20.98
US$ 29.19
US$ 25.34
